Kenya National Cancer Control Programme (NCCP) Implementation Guide
1.0.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Example Oncology Referral — From County Hospital to National Cancer Centre

Raw xml | Download


<ServiceRequest xmlns="http://hl7.org/fhir">
  <id value="OncologyReferralServiceRequestExample"/>
  <meta>
    <profile
             value="https://fhir.dha.go.ke/nccp/StructureDefinition/nccp-oncology-referral-service-request"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>Referral of a newly diagnosed breast cancer patient from Machakos County Hospital to KNH Oncology</p></div>
  </text>
  <extension
             url="https://fhir.dha.go.ke/nccp/StructureDefinition/nccp-referral-source-extension">
    <valueCode value="COUNTY-HOSPITAL"/>
  </extension>
  <status value="active"/>
  <intent value="order"/>
  <category>
    <coding>
      <system
              value="https://fhir.dha.go.ke/terminology/CodeSystem/sha-interventions-cs"/>
      <code value="SHA-ONCOLOGY-CONSULT"/>
      <display value="SHA: Oncology Consultation"/>
    </coding>
  </category>
  <code>
    <coding>
      <system
              value="https://fhir.dha.go.ke/terminology/CodeSystem/sha-interventions-cs"/>
      <code value="SHA-ONCOLOGY-CONSULT"/>
      <display value="SHA: Oncology Consultation"/>
    </coding>
  </code>
  <subject>🔗 
    <reference value="Patient/example-patient"/>
  </subject>
  <performer>🔗 
    <reference value="Organization/knh-oncology"/>
  </performer>
  <reasonCode>
    <coding>
      <system
              value="https://fhir.dha.go.ke/terminology/CodeSystem/condition-codes-cs"/>
      <code value="C50"/>
      <display value="C50 — Malignant neoplasm of breast"/>
    </coding>
  </reasonCode>
  <note>
    <text
          value="45-year-old female with newly diagnosed invasive ductal carcinoma left breast (T2N1M0, Stage IIB). Requires medical oncology review for systemic treatment planning."/>
  </note>
</ServiceRequest>